معرفی
Dr. R. Wijsman is a Clinical Professor at the Faculty of Medical Sciences, University of Groningen (UMCG), specializing in radiation oncology. They have been actively working as a radiotherapeut-oncoloog at UMCG since September 2017. Dr. Wijsman’s research focuses on radiation therapy outcomes in lung cancer patients, including toxicity management, quality of life assessment, and advancements in proton therapy. Their work integrates clinical practice with translational research, addressing challenges in radiation oncology such as cardiac toxicity and immunotherapy combinations.
Education and Career:
- MD from the University of Groningen (2003-2010)
- Training in Radiation Oncology at Radboudumc (Nijmegen) and Radiotherapiegroep (Arnhem) (2010-2017)
- PhD (2018) from Radboud University, Nijmegen, with a thesis on "Radiotherapy induced toxicity in lung cancer patients"
Research Interests:
Dr. Wijsman’s research emphasizes optimizing radiation therapy techniques to minimize adverse effects while enhancing efficacy. Key areas include radiation pneumonitis prevention, biomarker-driven treatment responses, and improving patient quality of life through tailored therapy. They also explore proton therapy advancements and AI-driven tumor segmentation for precision oncology.
Grants and Collaborations:
- Active collaborations with institutions like Radboudumc and the University of Groningen
- Focus on multi-institutional studies to validate treatment outcomes and toxicity models
Labs and Teams:
Participates in multidisciplinary teams at UMCG’s Department of Radiation Oncology, integrating clinical care with research to advance personalized radiation therapy strategies.
